Does NMN activate cancer cells?
Sep 24, 2024
Source: Cainiu Health
Dr. Qi Zhirong
Introduction
NMN refers to β-nicotinamide mononucleotide, which generally does not activate cancer cells. β-nicotinamide mononucleotide is a precursor of nicotinamide adenine dinucleotide (NAD+). NAD+ participates in various cellular metabolic processes, including DNA repair and energy metabolism, and helps slow down the aging process. Cancer patients are advised to choose appropriate treatment methods under the guidance of a physician.
NMN refers to β-nicotinamide mononucleotide, which generally does not activate cancer cells. The detailed analysis is as follows:
β-Nicotinamide mononucleotide is a precursor of nicotinamide adenine dinucleotide (NAD+). NAD+ participates in various metabolic processes within cells, including DNA repair and energy metabolism, and helps delay the aging process. In normal cells, β-nicotinamide mononucleotide may help protect cellular health by increasing NAD+ levels, without directly activating cancer cells.
β-Nicotinamide mononucleotide may have certain inhibitory effects on cancer cells. It may suppress cancer cell growth by regulating the cell cycle and reducing cell division. Furthermore, the antioxidant properties and DNA repair effects of β-nicotinamide mononucleotide may also help inhibit the spread of cancer cells to some extent.
Cancer patients are advised to choose appropriate treatment methods under the guidance of a physician, maintain a light diet during treatment, get adequate rest, and promote recovery.
